0001644600-23-000136.txt : 20230808 0001644600-23-000136.hdr.sgml : 20230808 20230808115926 ACCESSION NUMBER: 0001644600-23-000136 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20230808 DATE AS OF CHANGE: 20230808 EFFECTIVENESS DATE: 20230808 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Quadrant Biosciences Inc CENTRAL INDEX KEY: 0001651239 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 473417864 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-489069 FILM NUMBER: 231150096 BUSINESS ADDRESS: STREET 1: 505 IRVING AVENUE STREET 2: SUITE 3100 A-B CITY: SYRACUSE STATE: NY ZIP: 13210 BUSINESS PHONE: 607-227-4400 MAIL ADDRESS: STREET 1: 505 IRVING AVENUE STREET 2: SUITE 3100 A-B CITY: SYRACUSE STATE: NY ZIP: 13210 FORMER COMPANY: FORMER CONFORMED NAME: Motion Intelligence Inc. DATE OF NAME CHANGE: 20150818 D 1 primary_doc.xml X0708 D LIVE 0001651239 Quadrant Biosciences Inc 505 IRVING AVENUE SUITE 3100 A-B SYRACUSE NY NEW YORK 13210 607-227-4400 DELAWARE Motion Intelligence Inc. Corporation true Richard Uhlig 505 Irving Avenue Suite 3100 A-B Syracuse NY NEW YORK 13210 Executive Officer Director James Croke 505 Irving Avenue Suite 3100 A-B Syracuse NY NEW YORK 13210 Executive Officer Director Richard Bongo 505 Irving Avenue Suite 3100 A-B Syracuse NY NEW YORK 13210 Executive Officer Director Peter Cohen 505 Irving Avenue Suite 3100 A-B Syracuse NY NEW YORK 13210 Director Andrew Rock 505 Irving Avenue Suite 3100 A-B Syracuse NY NEW YORK 13210 Director Ira Fedder 505 Irving Avenue Suite 3100 A-B Syracuse NY NEW YORK 13210 Director Mary Ann Tyszko 505 Irving Avenue Suite 3100 A-B Syracuse NY NEW YORK 13210 Director Bryan Greene 505 Irving Avenue Suite 3100 A-B Syracuse NY NEW YORK 13210 Executive Officer Erica Ash 505 Irving Avenue 3100 A-B Syracuse NY NEW YORK 13210 Executive Officer Nicholas Gianadda 505 Irving Avenue 3100 A-B Syracuse NY NEW YORK 13210 Executive Officer Biotechnology Decline to Disclose 06b false 2023-07-27 false true true false 50000 35000000 3500000 31500000 false 6 0 0 1100000 true false Quadrant Biosciences Inc Richard Bongo Richard Bongo Chief Financial Officer 2023-08-08